Tawfik Ossama, Kimler Bruce F, Davis Marilyn, Stasik Christopher, Lai Sue-Min, Mayo Matthew S, Fan Fang, Donahue John K, Damjanov Ivan, Thomas Patricia, Connor Carol, Jewell William R, Smith Holly, Fabian Carol J
Department of Pathology and Laboratory Medicine, Kansas University Medical Center, 3901 Rainbow Boulevard, Kansas City, KS 66160, USA.
Virchows Arch. 2007 Jun;450(6):627-36. doi: 10.1007/s00428-007-0400-0. Epub 2007 Apr 26.
Breast carcinomas are graded according to the "Nottingham modification of the Bloom-Richardson system" (SBR). The system is hindered, however, by lack of precision in assessing all three parameters including nuclear grade, mitosis, and tubular formation, leading to an element of subjectivity. Our objective was to evaluate a new grading system [the nuclear grade plus proliferation (N+P) system] for subjectivity, ease, and better representation of tumor biology. Its components are nuclear grade and automated proliferation index. Invasive ductal carcinomas, consisting of 137 SBR grade I, 247 grade II, and 266 grade III, were re-evaluated by the N+P system. The two systems were compared with each other and correlated with patients' overall survival, tumor size, angiolymphatic invasion, lymph node status, and biomarker status including estrogen receptor, progesterone receptor, p53, epidermal growth factor receptor, BCL-2, and Her-2. Although there was an agreement between the two systems with histologic and prognostic parameters studied, there was 37% disagreement when grading individual tumors. Fifty-three percent of SBR grade II tumors were "down-graded" to N+P grade I, and 7% were "up-graded" to N+P grade III. Distinction among the different histologic grades for overall survival curves was better indicated by the N+P than the SBR system.
乳腺癌根据“布鲁姆 - 理查森系统的诺丁汉改良版”(SBR)进行分级。然而,该系统在评估包括核分级、有丝分裂和管状结构形成这三个参数时缺乏精确性,导致存在主观因素。我们的目的是评估一种新的分级系统[核分级加增殖(N + P)系统]在主观性、易用性以及对肿瘤生物学的更好表征方面的表现。其组成部分为核分级和自动增殖指数。对137例SBR I级、247例II级和266例III级的浸润性导管癌采用N + P系统进行重新评估。将这两种系统相互比较,并与患者的总生存期、肿瘤大小、血管淋巴管浸润、淋巴结状态以及生物标志物状态(包括雌激素受体、孕激素受体、p53、表皮生长因子受体、BCL - 2和Her - 2)进行关联分析。尽管在研究的组织学和预后参数方面两种系统存在一致性,但在对单个肿瘤进行分级时存在37%的分歧。53%的SBR II级肿瘤被“下调”至N + P I级,7%被“上调”至N + P III级。对于总生存曲线,N + P系统比SBR系统能更好地显示不同组织学分级之间的差异。